journal article·2024-07Open access

“Cicada Out of the Shell” Deep Penetration and Blockage of the HSP90 Pathway by ROS‐Responsive Supramolecular Gels to Augment Trimodal Synergistic Therapy

Fashun Li, Jianqin Yan, Chen Wei, Yi Zhao, Xiaowen Tang, Long Xu, Bin He, Yong Sun, Jing Chang, Yan Liang

Advanced Science· Volume 11· Issue 25

Abstract

Abstract Deep penetration and downregulation of heat shock protein (HSP) expression in multimodal synergistic therapy are promising approaches for curing cancer in clinical trials. However, free small‐molecule drugs and most drug vehicles have a low delivery efficiency deep into the tumor owing to poor drug penetration and hypoxic conditions at the tumor site. In this study, the objective is to use reactive oxygen species (ROS)‐responsive supramolecular gels co‐loaded with the photosensitizer Zn(II) phthalocyanine tetrasulfonic acid (ZnPCS4) and functionalized tetrahedral DNA (TGSAs) (G@P/TGSAs) to enhance deep tissue and cell penetration and block the HSP90 pathway for chemo‐ photodynamic therapy (PDT) ‐ photothermal therapy (PTT) trimodal synergistic therapy. The (G@P/TGSAs) are injected in situ into the tumor to release ZnPCS4 and TGSAs under high ROS concentrations originating from both the tumor and PDT. TGSAs penetrate deeply into tumor tissues and augment photothermal therapy by inhibiting the HSP90 pathway. Proteomics show that HSP‐related proteins and molecular chaperones are inhibited/activated, inhibiting the HSP90 pathway. Simultaneously, the TGSA‐regulated apoptotic pathway is activated. In vivo study demonstrates efficient tumor penetration and excellent trimodal synergistic therapy (45% tumor growth inhibition).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics School of Pharmacy Qingdao University Qingdao 266073 China

Department of Pharmacy Qingdao Women and Children's Hospital Qingdao 266034 China

Department of Recuperation Medicine Qingdao Special Service Sanatorium of PLA Navy Qingdao 266071 China

Department of Medicinal Chemistry School of Pharmacy Qingdao University Qingdao 266073 China

School of Materials Science and Chemical Engineering Ningbo University Ningbo 315211 China

National Engineering Research Center for Biomaterials Sichuan University Chengdu 610064 China

College of Marine Life Science Ocean University of China Qingdao 266003 China

Funding

Natural Science Foundation of Shandong Province

References (39)

Show source-provided references
1. 10.1002/adma.20210422310.1002/adma.202104223 ↗
2. 10.1002/adfm.20190878810.1002/adfm.201908788 ↗
3. 10.1016/j.biomaterials.2021.12113510.1016/j.biomaterials.2021.121135 ↗
4. Cui M. · Adv. Mater. · 2023 · 35
5. 10.1016/j.cej.2023.14764510.1016/j.cej.2023.147645 ↗
6. 10.1016/j.jconrel.2022.11.03910.1016/j.jconrel.2022.11.039 ↗
7. 10.1021/jacs.8b1314110.1021/jacs.8b13141 ↗
8. 10.1021/jacs.2c1280910.1021/jacs.2c12809 ↗
9. 10.1021/acsnano.3c0599110.1021/acsnano.3c05991 ↗
10. 10.1016/j.actbio.2023.01.03610.1016/j.actbio.2023.01.036 ↗
11. 10.1038/s41467-023-42740-210.1038/s41467-023-42740-2 ↗
12. 10.7150/thno.6378810.7150/thno.63788 ↗
13. 10.1016/j.jcis.2021.01.05210.1016/j.jcis.2021.01.052 ↗
14. Chang M. · Angew. Chem., Int. Ed. · 2022 · 61
15. 10.1016/j.bbcan.2020.18838110.1016/j.bbcan.2020.188381 ↗
16. 10.1016/j.jconrel.2022.09.01010.1016/j.jconrel.2022.09.010 ↗
17. 10.1073/pnas.160665511310.1073/pnas.1606655113 ↗
18. 10.1016/j.jconrel.2021.09.01710.1016/j.jconrel.2021.09.017 ↗
19. 10.1002/smll.20190050110.1002/smll.201900501 ↗
20. 10.1021/acs.nanolett.3c0123510.1021/acs.nanolett.3c01235 ↗
21. 10.1016/j.bioactmat.2023.10.02510.1016/j.bioactmat.2023.10.025 ↗
22. 10.1016/j.jconrel.2020.11.05010.1016/j.jconrel.2020.11.050 ↗
23. 10.1016/j.matdes.2022.11158410.1016/j.matdes.2022.111584 ↗
24. 10.1186/s12951-021-01164-010.1186/s12951-021-01164-0 ↗
25. 10.1016/j.semcancer.2022.01.00110.1016/j.semcancer.2022.01.001 ↗
26. 10.1021/acs.jmedchem.6b0049210.1021/acs.jmedchem.6b00492 ↗
27. 10.1021/acs.jmedchem.3c0000710.1021/acs.jmedchem.3c00007 ↗
28. 10.1002/adma.20210782010.1002/adma.202107820 ↗
29. 10.1002/advs.20220068110.1002/advs.202200681 ↗
30. 10.1021/acsnano.2c1009410.1021/acsnano.2c10094 ↗
31. 10.1016/j.biomaterials.2016.07.02510.1016/j.biomaterials.2016.07.025 ↗
32. 10.1021/jacs.2c0209610.1021/jacs.2c02096 ↗
33. 10.1016/j.carbpol.2022.11945510.1016/j.carbpol.2022.119455 ↗
34. 10.1021/acs.nanolett.3c0253110.1021/acs.nanolett.3c02531 ↗
35. 10.1016/j.biomaterials.2016.05.02310.1016/j.biomaterials.2016.05.023 ↗
36. 10.3390/pharmaceutics1508216110.3390/pharmaceutics15082161 ↗
37. 10.1038/s41565-020-00844-610.1038/s41565-020-00844-6 ↗
38. 10.1126/sciadv.aax093710.1126/sciadv.aax0937 ↗
39. 10.1039/D1NR01155C10.1039/D1NR01155C ↗